Temazepam is a white, crystalline substance that comes in capsule form with a strength of 7.5 mg, 15 mg, 22.5 mg, and 30 mg Capsules. It has been advised that this medication should be recommended for patients with short-term insomnia, instructions in the prescription should indicate that Restoril or temazepam should be used for short periods (7 to 10 days). The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated.
Restoril (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Restoril(temazepam) should be used for short periods (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
Concomitant use of benzodiazepines, including Restoril, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Benzodiazepines may cause fetal harm when administered to a pregnant woman.